BCRX: Target practice for shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : BCRX: Target practice for shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (60)	8/27/1999 12:29:00 PM
From: scaram(o)uche	Read Replies (1) of 96

Talking about crap.... throw in some burn, and bring that down to 60 from 80. Bulls, of course, might say that the 40 is low. The company has a diversified research program. One needs to think in terms of what JNJ would pay for the company, given success in flu. Just because a company has been traditionally selling for $X/share doesn't mean that it's not worth $4X/share. Happens all the time in biotech. The "short any biotech that goes up" mentality has led to big winners in the past. This was often due to ignorance in the face of dogma (issues like ENMD excepted), and that dogma is now blasted to pieces.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next